Management of adjuvant settings for Stage III melanoma patients in France prior to checkpoint inhibitors: epidemiological data from the RIC-Mel database
暂无分享，去创建一个
C. Lebbé | B. Dréno | A. Dupuy | S. Dalle | N. Meyer | A. Khammari | L. Mortier | C. Dutriaux | F. Skowron | M. Leccia | H. Montaudié | J. Nguyen | P. Célérier | E. Varey | C. Lesage | S. Dalac-Rat | É. Varey